Oligonucleotides targeted to angiotensinogen mrna

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 9/127 (2006.01) A61K 31/70 (2006.01) C07H 21/00 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2248932

Oligonucleotides, and compositions thereof, are disclosed which can be administered to human subjects to inhibit the expression of angiotensinogen to thereby control angiotensinogen induced hypertension.

L'invention concerne des oligonucléotides et des compositions de ces derniers qui peuvent être administrés à l'homme pour inhiber l'expression de l'angiotensinogène. Cela permet ainsi de combattre l'hypertension induite par l'angiotensinogène.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oligonucleotides targeted to angiotensinogen mrna does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligonucleotides targeted to angiotensinogen mrna, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides targeted to angiotensinogen mrna will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1833775

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.